Virginia Kaklamani

Breast medical oncologist at UT San Antonio with expertise in breast cancer clinical trials and treatment strategies; serves as the featured expert guest providing detailed analysis of ESMO 2025 breast cancer data in this episode.

Best podcasts with Virginia Kaklamani

Ranked by the Snipd community

Oct 30, 2025 • 22min

Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION

Dr. Virginia Kaklamani, a breast medical oncologist from UT San Antonio specializing in clinical trials, shares crucial insights on ESMO 2025 breast cancer data. She discusses breakthrough findings from the MonarchE and NATALEE studies, emphasizing the overall survival benefits of abemaciclib. The conversation dives into the VIKTORIA1 trial results for metastatic HR+ disease and examines the promising efficacy of TDXd in HER2+ breast cancer settings. Kaklamani also addresses treatment strategies for triple negative breast cancer, offering community oncologists practical takeaways.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app